A multimodal AI model may improve recurrence risk stratification in early breast cancer

An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, HER2-negative breast cancer, according to…

Continue Reading

News Source: medicalxpress.com